News

Further research examining a possible association between smoking, which was found more frequently in nADAb-positive patients, is warranted.

“These results show that emotional distress is associated with higher frequency of PFAPA attacks, thus may be considered as an environmental trigger for PFAPA attack," investigators stated.

Additional doses improved seroconversion and most vaccinated patients with lupus experienced a generally mild course of the disease.

Cancer is linked to many chronic conditions, but what is its relationship with rheumatoid arthritis? Test your knowledge with this quiz.

Novartis announces the EC expanded on the approval of secukinumab in EU to include pediatric patients with childhood arthritic conditions: juvenile idiopathic arthritis, enthesitis-related arthritis, and juvenile psoriatic arthritis.

Over a 40-year follow-up, approximately one-quarter of the study cohort with juvenile arthritis were reported to have active uveitis.

Higher energy and longer symptom duration at diagnosis were protective factors against medication failure.

New data suggests that a third COVID-19 booster might be warranted in children with juvenile idiopathic arthritis.

According to preliminary data, patients with JIA experience the same safety and immunogenicity as healthy individuals when vaccinated with the Pfizer COVID-19 vaccine.

Data suggests baricitinib not only significantly reduced the time to flares but also the frequency of flares in patients with JIA when compared with placebo.

A high percentage of pediatric patients with JIA do not achieve inactive disease during the first 2 years following diagnosis.

A new study revealed no significant relationship between patients with juvenile idiopathic arthritis and exposure to maternal infection, however, investigators said that suggestive evidence of differential sex-specific results indicate a need for further study.

In this Q&A, Rubén Queiro, MD, PhD, discussed the findings of his study that examined the variables associated with achieving minimal disease activity in patients with recent-onset psoriatic arthritis.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 9, 2022.

The decision was based on results from the MIRROR trial, which evaluated the concomitant use of pegloticase with methotrexate.

The French national healthcare database (SNDS) was used to evaluate malignancy between patients with RA initiating bDMARDs and those continuing csDMARDs.

In the prospective, open-labeled trial, patients were randomly assigned to receive either low-dose benzbromarone or low-dose febuxostat for 12 weeks.

Many people now use activity trackers to assess their activity levels, but what role can these devices play in managing rheumatoid arthritis patients? Test your knowledge with this quiz.

Results of a proof-of-concept trial suggest early intervention with methotrexate could alter the disease course and improve symptoms in patients with arthralgia at risk of progressing to rheumatoid arthritis

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending July 2, 2022.

“The differential contribution of IL-6 and IL-17 pathways to the pathogenesis of psoriatic arthritis is not fully understood,” investigators stated.

The approval and implementation of new drugs can vastly improve quality of life and reduce signs and symptoms of disease burden in patients with rheumatic and dermatologic diseases.

The Committee for Medicinal Products for Human Use (CHMP) recommends approving upadacitinib 15 mg, once daily, for the treatment of active non-radiographic axial spondyloarthritis in adults patients with inflammation and inadequate response to NSAIDs.

Take a few minutes to discover Rheumatology Network's most-viewed EULAR 2022 coverage.

The approvals were based on results from the JUNIPERA trial, which showed secukinumab reduced the risk of flare and disease activity when compared with placebo over 2 years in pediatric patients with ERA and JPsA.

"The challenges of an existing rheumatologist workforce shortage, changing workforce demographics, and physician burnout have been compounded by the COVID-19 pandemic."

An analysis of real-world data from more than 6500 patients suggests insulin users had a greater risk of fracture than patients using metformin, but this became attenuated among patients using a combination of insulin and metformin.

Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending June 25, 2022.

Teodora Staeva, PhD, discusses how Lupus Research Alliance's is recognizing the critical contributions of underrepresented minority researchers through their Diversity in Lupus Research Award.

"Remote care interventions have become more widespread over the past 20 years, with presumed benefits for diagnosis, treatment, rehabilitation and follow-up monitoring of patients.”